Istituto Nazionale Tumori | "Fondazione Pascale" — Naples, Italy

Public research footprint of Istituto Nazionale Tumori | "Fondazione Pascale", compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Following Complete or Partial Response to Platinum Based Chemotherapy · Solid Tumors · Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer

Recently updated registry entries

NCT07227350 — L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) (Recruiting)
NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)
NCT06427941 — A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Istituto Nazionale Tumori | "Fondazione Pascale"?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.